| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pure Biologics Spólka Akcyjna (STU: PQB)
PQB Technical Analysis
5
| As on 12th Sep 2025 PQB STOCK Price closed @ 1.64 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.12 & Strong Sell for SHORT-TERM with Stoploss of 1.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PQBSTOCK Price
| Open | 1.71 | Change | Price | % |
| High | 1.71 | 1 Day | 0.48 | 41.38 |
| Low | 1.64 | 1 Week | 0.20 | 13.89 |
| Close | 1.64 | 1 Month | 0.66 | 67.35 |
| Volume | N/A | 1 Year | -0.65 | -28.38 |
| 52 Week High 6.38 | 52 Week Low 0.96 | ||||
STU Germany Most Active Stocks
| 9OC | 0.00 | % |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TINC | 0.01 | -1.50% |
| PGF | 19.13 | -90.20% |
| PGF | 19.13 | -90.20% |
| CVJ | 0.01 | % |
STU Germany Top Gainers Stocks
STU Germany Top Losers Stocks
| PQB Daily Charts |
PQB Intraday Charts |
Whats New @ Bazaartrend |
PQB Free Analysis |
|
|
PQB Important Levels Intraday
| RESISTANCE | 1.77 |
| RESISTANCE | 1.73 |
| RESISTANCE | 1.70 |
| RESISTANCE | 1.68 |
| SUPPORT | 1.60 |
| SUPPORT | 1.58 |
| SUPPORT | 1.55 |
| SUPPORT | 1.51 |
PQB Forecast September 2025
| 4th UP Forecast | 3.01 |
| 3rd UP Forecast | 2.57 |
| 2nd UP Forecast | 2.3 |
| 1st UP Forecast | 2.03 |
| 1st DOWN Forecast | 1.25 |
| 2nd DOWN Forecast | 0.98 |
| 3rd DOWN Forecast | 0.71 |
| 4th DOWN Forecast | 0.27 |
PQB Weekly Forecast
| 4th UP Forecast | 2.53 |
| 3rd UP Forecast | 2.24 |
| 2nd UP Forecast | 2.07 |
| 1st UP Forecast | 1.89 |
| 1st DOWN Forecast | 1.39 |
| 2nd DOWN Forecast | 1.21 |
| 3rd DOWN Forecast | 1.04 |
| 4th DOWN Forecast | 0.75 |
PQB Forecast2025
| 4th UP Forecast | 12.62 |
| 3rd UP Forecast | 9.1 |
| 2nd UP Forecast | 6.92 |
| 1st UP Forecast | 4.75 |
| 1st DOWN Forecast | -1.47 |
| 2nd DOWN Forecast | -3.64 |
| 3rd DOWN Forecast | -5.82 |
| 4th DOWN Forecast | -9.34 |
Pure Biologics Spólka Akcyjna ( STU Germany Symbol : PQB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PQB Business Profile
Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of new therapies and diagnostic methods in the field of immuno-oncology and rare diseases. It is also involved in the production, purification, analysis, and characterization of recombinant proteins and antibodies, protein engineering and formulation, genome sequencing, proteomic analysis, and bioinformatics; development and validation of assays; development of measurement methods and the derivation of stable cell lines; and provision of contract research service related to lead identification from antibody and aptamer libraries. In addition, the company offers medical devices; cancer diagnostics products; PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use; and Pure Select2, a platform for in vitro selection of recombinant human antibody fragments that recognize a chosen molecular target, including whole cells. Further, it undertakes partnership projects in cooperation with various institutions, which include Molecular Analytical Robotics Assays (MARA), which focuses on the development of modern nanotechnologies in the diagnosis and treatment of bacterial infections; MAGBBRIS project that investigate growth factors secreted by endothelial progenitor cells; and APIFAG project, a bacteriophage preparation intended for the prevention and treatment of American Foulbrood and European Foulbrood in honeybees, as well as various other projects funded by the European Union. The company was founded in 2010 and is based in Wroclaw, Poland. Address: ul. Dunska 11, Wroclaw, Poland, 54-427
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service